Generation Z (1997–2012). Everything on demand, including healthcare
MHE April 2024
Millennials (1981–1996), burdened by health problems and costly
On specialty drugs, the Prime acquisition and vertical integration
Gen X (1965–1980), still traditional — and stuck in the middle.
The Boomers (1946–1964): Active but aging
Ten biosimilars to Humira are now on the market, but AbbVie’s Skyrizi and Rinvoq are soaking up revenues as Humira’s sales fall off.
The imperative to upgrade healthcare technology infrastructure is clear, but the returns from such investment are anything but.
New federal rules set time requirements for some insurers.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
California PBM Law is a Starting Point for Real Transparency
2
Topical Ruxolitinib Cream Rapidly Repigments Vitiligo Lesions, Study Finds
3
WHO Global Report on Antimicrobial Resistance Sheds Light on Growing Threat
4
FDA Accepts NDA for Investigational Maintenance Asthma Treatment
5
